| Business Summary | | Covance
Inc.
is
a
contract
research
organization
providing
product
development
services
on
a
worldwide
basis
to
the
pharmaceutical,
biotechnology
and
medical
device
industries.
The
Company
also
provides
health
economics
and
outcomes
services
for
managed
care
organizations,
hospitals
and
other
healthcare
providers,
and
laboratory
testing
services
to
the
chemical,
agrochemical
and
food
industries.
The
services
Covance
provides
constitute
two
segments
for
financial
reporting
purposes,
early
development
services,
which
include
preclinical
and
Phase
I
clinical
service
capabilities,
and
late-stage
development
services,
which
include
clinical
development,
clinical
support,
biomanufacturing
and
commercialization
services. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CVD
is
a
contract
research
organization
providing
integrated
product
development
services
to
biotechnology,
pharmaceutical
and
medical
device
industries.
For
the
six
months
ended
6/30/01,
revenues
increased
8%
to
$455.1
million.
Net
income
totaled
$29.1
million,
up
from
$6.2
million.
Revenues
reflect
strond
demand
for
the
Company's
toxicology
business.
Net
income
reflects
the
inclusion
of
a
$30.8
million
gain
on
the
sale
of
business. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Christopher Kuebler, 47 Chairman,
Pres, CEO, Director | $1.2M | William Klitgaard, 47 CFO,
Sr. VP, Treasurer | -- | Charles Harwood, Jr, 47 Sr.
VP, Venture Devel. | -- | Joseph Herring, 45 Corp.
Sr. VP and Pres, Early Devel. Services | 708K | Alan Horgan, 44 Corp.
Sr. VP and Pres, Clinincal Devel. | 571K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|